Form 4 for ANVS Annovis Bio, Inc.
Accepted 2026-05-21 20:11:23 ET · period of report 2026-05-20 · accession 0001104659-26-065311 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-21 20:11 | 2026-05-20 | ANVS | Hoffman Michael B | Dir | P - Purchase | $1.87 | +76.3K | 3.36M | +2% | +$142.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-20 | P | A | 2,562 | $1.75 | 3,291,101 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-20 | P | A | 18,849 | $1.80 | 3,309,950 | D | — | — | |
| 3 | Common | Common Stock | 2026-05-20 | P | A | 54,933 | $1.90 | 3,364,883 | D | — | — |